Change in Magnetic Anisotropy at the Surface and in the Bulk of FINEMET Induced by Swift Heavy Ion Irradiation

57 Fe transmission and conversion electron Mössbauer spectroscopy as well as XRD were used to study the effect of swift heavy ion irradiation on stress-annealed FINEMET samples with a composition of Fe73.5 Si13.5 Nb3 B9 Cu1. The XRD of the samples indicated changes neither in the crystal structure nor in the texture of irradiated ribbons as compared to those of non-irradiated ones. However, changes in the magnetic anisotropy both in the bulk as well as at the surface of the FINEMET alloy ribbons irradiated by 160 MeV132 Xe ions with a fluence of 1013 ion cm−2 were revealed via the decrease in relative areas of the second and fifth lines of the magnetic sextets in the corresponding Mössbauer spectra. The irradiation-induced change in the magnetic anisotropy in the bulk was found to be similar or somewhat higher than that at the surface. The results are discussed in terms of the defects produced by irradiation and corresponding changes in the orientation of spins depending on the direction of the stress generated around these defects. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.CZ-11/2007, MEB040806; Ministry of Education and Science of the Russian Federation, Minobrnauka: FEUZ-2020-0060; Hungarian Scientific Research Fund, OTKA: K100424, K115784, K115913, K43687, K68135; Joint Institute for Nuclear Research, JINR; Univerzita Palackého v Olomouci: CZ.02.1.01/0.0/0.0/17_049/0008408, IGA_PrF_2022_003, IGA_PrF_2022_013; Ural Federal University, UrFU: 04-5-1131-2017/2021; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, NKFIHFunding: The research was supported by grants from the Hungarian National Research, Development and Innovation Office (OTKA projects No K43687, K68135, K100424, K115913, K115784) and by the Czech-Hungarian Intergovernmental Fund, Grant No. CZ-11/2007 (MEB040806). M.I.O. was supported by the Ministry of Science and Higher Education of the Russian Federation, project No. FEUZ-2020-0060. Additionally, M.I.O. was supported in part by the Ural Federal University project within the Priority-2030 Program, funded from the Ministry of Science and Higher Education of the Russian Federation. This work was also supported by the project “Swift heavy ions in research of iron-bearing nanomaterials”, No. of theme 04-5-1131-2017/2021, solved in cooperation with the Czech Republic and the JINR (3 + 3 projects), and also by internal IGA grant of Palacký University (IGA_PrF_2022_003). The authors from Palacký University Olomouc want to thank the facilitators of project CZ.02.1.01/0.0/0.0/17_049/0008408 of the Ministry of Education, Youth & Sports of the Czech Republic for their support as well.Acknowledgments: We are grateful to Z. Klencsár (Centre for Energy Research, Budapest), M. Miglierini (Technical University, Bratislava), I. Dézsi (Wigner Research Centre for Physics, Budapest), S. Kubuki, and K. Nomura (Tokyo Metropolitan University, Tokyo) for their participation in discussions, and L. Krupa (Czech Technical University in Prague, Czech Republic and Joint Institute for Nuclear Research, Dubna) for his help with the organization of project cooperation. The support by grants from the Hungarian National Research, Development and Innovation Office and by the Czech-Hungarian Intergovernmental Fund, Grant No. CZ-11/2007 (MEB040806) are acknowledged. M.I.O. is grateful for support from the Ministry of Science and Higher Education of the Russian Federation and from the Ural Federal University project within the Priority-2030 Program. This work was also carried out within the Agreement of Cooperation between the Ural Federal University (Ekaterinburg) and the Eötvös Loránd University (Budapest) and within the Memorandum of Understanding between the Ural Federal University (Ekaterinburg) and the Palacký University (Olomouc). Authors acknowledge the support of the project “Swift heavy ions in research of iron-bearing nanomaterials”, No. of theme 04-5-1131-2017/2021, solved in cooperation with the Czech Republic and the JINR (3 + 3 projects). Authors from Palacký University Olomouc appreciate the internal IGA grant of Palacký University (IGA_PrF_2022_013) and thank the facilitators of the project CZ.02.1.01/0.0/0.0/17_049/0008408 of the Ministry of Education, Youth & Sports of the Czech Republic as well

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

Objectives: There are currently few data on the long-term risk of cancer and death in individuals taking raltegravir (RAL). The aim of this analysis was to evaluate whether there is evidence for an association. Methods: The EuroSIDA cohort was divided into three groups: those starting RAL-based combination antiretroviral therapy (cART) on or after 21 December 2007 (RAL); a historical cohort (HIST) of individuals adding a new antiretroviral (ARV) drug (not RAL) to their cART between 1 January 2005 and 20 December 2007, and a concurrent cohort (CONC) of individuals adding a new ARV drug (not RAL) to their cART on or after 21 December 2007. Baseline characteristics were compared using logistic regression. The incidences of newly diagnosed malignancies and death were compared using Poisson regression. Results: The RAL cohort included 1470 individuals [with 4058 person-years of follow-up (PYFU)] compared with 3787 (4472 PYFU) and 4467 (10 691 PYFU) in the HIST and CONC cohorts, respectively. The prevalence of non-AIDS-related malignancies prior to baseline tended to be higher in the RAL cohort vs. the HIST cohort [adjusted odds ratio (aOR) 1.31; 95% confidence interval (CI) 0.95–1.80] and vs. the CONC cohort (aOR 1.89; 95% CI 1.37–2.61). In intention-to-treat (ITT) analysis (events: RAL, 50; HIST, 45; CONC, 127), the incidence of all new malignancies was 1.11 (95% CI 0.84–1.46) per 100 PYFU in the RAL cohort vs. 1.20 (95% CI 0.90–1.61) and 0.83 (95% CI 0.70–0.99) in the HIST and CONC cohorts, respectively. After adjustment, there was no evidence for a difference in the risk of malignancies [adjusted rate ratio (RR) 0.73; 95% CI 0.47–1.14 for RALvs. HIST; RR 0.95; 95% CI 0.65–1.39 for RALvs. CONC] or mortality (adjusted RR 0.87; 95% CI 0.53–1.43 for RALvs. HIST; RR 1.14; 95% CI 0.76–1.72 for RALvs. CONC). Conclusions: We found no evidence for an oncogenic risk or poorer survival associated with using RAL compared with control groups.Peer reviewe

Plasma–liquid interactions: a review and roadmap

Plasma–liquid interactions represent a growing interdisciplinary area of research involving plasma science, fluid dynamics, heat and mass transfer, photolysis, multiphase chemistry and aerosol science. This review provides an assessment of the state-of-the-art of this multidisciplinary area and identifies the key research challenges. The developments in diagnostics, modeling and further extensions of cross section and reaction rate databases that are necessary to address these challenges are discussed. The review focusses on non-equilibrium plasmas

Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICU.

OBJECTIVES: To develop a scoring system model that predicts mortality within 30 days of admission of patients older than 80 years admitted to intensive care units (ICUs). DESIGN: Prospective cohort study. SETTING: A total of 306 ICUs from 24 European countries. PARTICIPANTS: Older adults admitted to European ICUs (N = 3730; median age = 84 years [interquartile range = 81-87 y]; 51.8% male). MEASUREMENTS: Overall, 24 variables available during ICU admission were included as potential predictive variables. Multivariable logistic regression was used to identify independent predictors of 30-day mortality. Model sensitivity, specificity, and accuracy were evaluated with receiver operating characteristic curves. RESULTS: The 30-day-mortality was 1562 (41.9%). In multivariable analysis, these variables were selected as independent predictors of mortality: age, sex, ICU admission diagnosis, Clinical Frailty Scale, Sequential Organ Failure Score, invasive mechanical ventilation, and renal replacement therapy. The discrimination, accuracy, and calibration of the model were good: the area under the curve for a score of 10 or higher was .80, and the Brier score was .18. At a cut point of 10 or higher (75% of all patients), the model predicts 30-day mortality in 91.1% of all patients who die. CONCLUSION: A predictive model of cumulative events predicts 30-day mortality in patients older than 80 years admitted to ICUs. Future studies should include other potential predictor variables including functional status, presence of advance care plans, and assessment of each patient's decision-making capacity

Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

Objectives The aim of the study was to establish a methodology for evaluating the hepatitis C continuum of care in HIV/hepatitis C virus (HCV)-coinfected individuals and to characterize the continuum in Europe on 1 January 2015, prior to widespread access to direct-acting antiviral (DAA) therapy. Methods Stages included in the continuum were as follows: anti-HCV antibody positive, HCV RNA tested, currently HCV RNA positive, ever HCV RNA positive, ever received HCV treatment, completed HCV treatment, follow-up HCV RNA test, and cure. Sustained virological response (SVR) could only be assessed for those with a follow-up HCV RNA test and was defined as a negative HCV RNA result measured > 12 or 24 weeks after stopping treatment. Results Numbers and percentages for the stages of the HCV continuum of care were as follows: anti-HCV positive (n = 5173), HCV RNA tested (4207 of 5173; 81.3%), currently HCV RNA positive (3179 of 5173; 61.5%), ever HCV RNA positive (n = 3876), initiated HCV treatment (1693 of 3876; 43.7%), completed HCV treatment (1598 of 3876; 41.2%), follow-up HCV RNA test to allow SVR assessment (1195 of 3876; 30.8%), and cure (629 of 3876; 16.2%). The proportion that achieved SVR was 52.6% (629 of 1195). There were significant differences between regions at each stage of the continuum (P <0.0001). Conclusions In the proposed HCV continuum of care for HIV/HCV-coinfected individuals, we found major gaps at all stages, with almost 20% of anti-HCV-positive individuals having no documented HCV RNA test and a low proportion achieving SVR, in the pre-DAA era.Peer reviewe

Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study.

BACKGROUND: The number of intensive care patients aged ≥ 80 years (Very old Intensive Care Patients; VIPs) is growing. VIPs have high mortality and morbidity and the benefits of ICU admission are frequently questioned. Sepsis incidence has risen in recent years and identification of outcomes is of considerable public importance. We aimed to determine whether VIPs admitted for sepsis had different outcomes than those admitted for other acute reasons and identify potential prognostic factors for 30-day survival. RESULTS: This prospective study included VIPs with Sequential Organ Failure Assessment (SOFA) scores ≥ 2 acutely admitted to 307 ICUs in 21 European countries. Of 3869 acutely admitted VIPs, 493 (12.7%) [53.8% male, median age 83 (81-86) years] were admitted for sepsis. Sepsis was defined according to clinical criteria; suspected or demonstrated focus of infection and SOFA score ≥ 2 points. Compared to VIPs admitted for other acute reasons, VIPs admitted for sepsis were younger, had a higher SOFA score (9 vs. 7, p < 0.0001), required more vasoactive drugs [82.2% vs. 55.1%, p < 0.0001] and renal replacement therapies [17.4% vs. 9.9%; p < 0.0001], and had more life-sustaining treatment limitations [37.3% vs. 32.1%; p = 0.02]. Frailty was similar in both groups. Unadjusted 30-day survival was not significantly different between the two groups. After adjustment for age, gender, frailty, and SOFA score, sepsis had no impact on 30-day survival [HR 0.99 (95% CI 0.86-1.15), p = 0.917]. Inverse-probability weight (IPW)-adjusted survival curves for the first 30 days after ICU admission were similar for acute septic and non-septic patients [HR: 1.00 (95% CI 0.87-1.17), p = 0.95]. A matched-pair analysis in which patients with sepsis were matched with two control patients of the same gender with the same age, SOFA score, and level of frailty was also performed. A Cox proportional hazard regression model stratified on the matched pairs showed that 30-day survival was similar in both groups [57.2% (95% CI 52.7-60.7) vs. 57.1% (95% CI 53.7-60.1), p = 0.85]. CONCLUSIONS: After adjusting for organ dysfunction, sepsis at admission was not independently associated with decreased 30-day survival in this multinational study of 3869 VIPs. Age, frailty, and SOFA score were independently associated with survival

Large-Diameter Single-Wall Carbon Nanotubes Formed Alongside Small-Diameter Double-Walled Carbon Nanotubes

Samples containing a majority of either single-wall carbon nanotubes (SWCNTs) or double-walled carbon nanotubes (DWCNTs) are prepared in the same catalytic chemical vapor deposition conditions but using slightly different catalytic materials, based on alumina impregnated with iron and molybdenum salts. There is a sharp SWCNTs-to-DWCNTs transition. By contrast to the usual findings, the selectivity is not correlated to the size of the iron-based catalyst nanoparticles, nor does the transition occur upon a decreasing carbon/catalyst ratio. The result is attributed to the increasing MoO3 concentration inducing modifications of the gas atmosphere, such as the formation of more reactive C2 species through C2H4 dissociation, which thus favors the nucleation and growth of a DWCNT. In the DWCNT sample, the average diameter of the SWCNTs is higher than the average outer diameter of the DWCNTs, which is uncommon, as many authors stress that SWCNTs show a lower diameter than DWCNTs. The study could provide guidelines for the synthesis of very small diameter DWCNTs